|
|
Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
OF THE INVENTION The invention described herein is directed to pharmaceutical compositions that provide for the controlled release of an active ingredient in the ...
|
|
|
Dispersion polymers for ethylene quench water clarification
We claim: 1. A method of removing emulsified oil from ethylene quench water, the method comprising the step of treating the oil-containing water with an effective amount ...
|
|
|
Corneal angiogenesis inhibitor
What is claimed is: 1. A method for treating corneal neovasculariztion which comprises: administering an effective amount of interferon .beta. for treating corneal ...
|
|
|
Methods and formulations for use in treating oophorectomized women
OF THE INVENTION Pursuant to the present invention, the regimen comprises a slow-release (or depot) formulation which is effective for an extended period of time. D...
|
|
|
Treatment of sexual dysfunction in certain patient groups
OF THE INVENTION The present invention relates to methods for the treatment of sexual dysfunction in males and females (including but not limited to erectile ...
|
|
|
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST*** *** NO IMAGES AVAILABLE*** Compositions, methods and devices for the transdermal delivery of drugs
OF THE INVENTION The present invention provides compositions comprising (i) a gelling agent consisting of methylcellulose or at least one natural gum, or a mixture ...
|
|
|
Treatment of sexual dysfunction in certain patient groups
OF THE INVENTION The present invention relates to methods for the treatment of sexual dysfunction in males and females (including but not limited to erectile ...
|
|
|
Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
This invention is therefore aimed at solving the above-mentioned shortcoming of adenosinergic approaches, while obtaining either analgesic (anesthetic) or protective ...
|
|
|
Oil composition
What is claimed is: 1. An oil composition, comprising about 0.1 to 59.8% by weight of a triglyceride, about 40 to 99.7% by weight of a diglyceride, about 0.1 to 10% by ...
|
|
|
Blocking agents of EDRF effect or formation for the treatment of shock
We claim: 1. A therapeutical composition of matter for the treatment by perfusion of shock states comprising as an essential ingredient therein an effective amount of a ...
|